Grab These 3 Healthcare Mutual Funds for Steady Returns

One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Among the sector players, many pharmaceutical companies also pay out regular dividends.Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of broad diversification and analytical insight.Below, we share with you three top-ranked Healthcare mutual funds, namely Fidelity Advisor Biotechnology Fund FBTIX, Janus Henderson Global Life Sciences JNGLX and Vanguard Health Care Fund VGHCX. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.Fidelity Advisor Biotechnology Fund seeks capital appreciation. FBTIX invests most of its assets in securities of companies principally engaged in the research, development, manufacture and distribution of various biotechnological products, services and processes. For investment purposes, FBTIX uses fundamental analysis of factors such as each issuer's financial condition and industry position.Fidelity Advisor Biotechnology Fund has three-year annualized returns of 2.7%. As of July 2024, FBTIX held 85 issues, with 18.2% of its assets invested in AbbVie.Janus Henderson Global Life Sciences invests most of its assets, along with borrowings, if any, in securities of companies that, according to its portfolio managers, have a life science orientation. JNGLX has a fundamental policy to invest at least a small portion of its assets in companies that belong to the "life sciences" sector.Janus Henderson Global Life Sciences has three-year annualized returns of 2.7%. JNGLX has an expense ratio of 0.80% compared to the category average of 0.98%.Vanguard Health Care Fund seeks long-term capital growth and dividend income. VGHCX invests in common stocks of companies in a variety of segments of the healthcare industry, including pharmaceutical firms, designers and manufacturers of medical equipment and supplies, operators of hospitals and other healthcare facilities, and biotechnological research. Vanguard Health Care Fund has three-year annualized returns of 0.9%. Rebecca Sykes has been one of the fund managers of VGHCX since 2023.To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.Want key mutual fund info delivered straight to your inbox?Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpView All Zacks #1 Ranked Mutual FundsWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (VGHCX): Fund Analysis Report Get Your Free (FBTIX): Fund Analysis Report Get Your Free (JNGLX): Fund Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks